Dose AI tracks your injection schedule, rotates injection sites for you, and reminds you when the next shot is due
Common side effects seen in retatrutide reporting In the Phase 2 trial, the most common adverse events were gastrointestinal and doserelated, mostly mild to moderate
GLP-1 therapies are transforming the management of obesity, Type 2 diabetes, cardiovascular disease, and metabolic disorders, creating a market expected to exceed hundreds of billions of dollars over the coming decade
Below the paywall, Ive highlighted the main points of our 1 year annual review for our key themes as they relate to GLP-1s
While compounded GLP-1s might have seemed like a smart way to save money or skip waitlists, the FDA ban makes it clear that these shortcuts arent worth the risk to your health
By continuing you agree to our Terms and Privacy Policy